These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 21147765)

  • 21. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of regional lymph node status in canine mammary carcinomas.
    Szczubiał M; Łopuszynski W
    Vet Comp Oncol; 2011 Dec; 9(4):296-303. PubMed ID: 22077411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours.
    Cassali GD; Gobbi H; Malm C; Schmitt FC
    Cytopathology; 2007 Jun; 18(3):191-6. PubMed ID: 17573766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables.
    Matos AJ; Lopes C; Carvalheira J; Santos M; Rutteman GR; Gärtner F
    J Comp Pathol; 2006; 134(2-3):182-9. PubMed ID: 16545841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
    Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
    Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of 14-3-3 σ protein in normal and neoplastic canine mammary gland.
    Suárez-Bonnet A; Herráez P; Martín de las Mulas J; Rodríguez F; Déniz JM; Espinosa de los Monteros A
    Vet J; 2011 Dec; 190(3):345-51. PubMed ID: 21251859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification and grading of canine mammary tumors.
    Goldschmidt M; Peña L; Rasotto R; Zappulli V
    Vet Pathol; 2011 Jan; 48(1):117-31. PubMed ID: 21266722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine mammary tumours as a model to study human breast cancer: most recent findings.
    Queiroga FL; Raposo T; Carvalho MI; Prada J; Pires I
    In Vivo; 2011; 25(3):455-65. PubMed ID: 21576423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
    Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
    Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
    De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
    Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-associated carbohydrate antigens: Sialyl Lea and T/Tn antigens in canine mammary tumors.
    Nowak M; Madej J; Dziegiel P; Lopuszynski W; Rodo A; Ugorski M
    Vet Pathol; 2009 Mar; 46(2):222-6. PubMed ID: 19261632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canine mammary tumour cell lines established in vitro.
    Hellmén E
    J Reprod Fertil Suppl; 1993; 47():489-99. PubMed ID: 8229968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study of those histopathologic parameters predictive of invasion of the lymphatic system by canine mammary carcinomas.
    Rasotto R; Zappulli V; Castagnaro M; Goldschmidt MH
    Vet Pathol; 2012 Mar; 49(2):330-40. PubMed ID: 21670194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
    Faustino AM; van Garderen E; Schalken JA; Nederbragt H
    J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological study of canine mammary gland during the oestrous cycle.
    Santos M; Marcos R; Faustino AM
    Reprod Domest Anim; 2010 Oct; 45(5):e146-54. PubMed ID: 19895392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
    Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
    Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors.
    Hezmee MN; Kyaw-Tanner M; Lee JY; Shiels IA; Rolfe B; Woodruff T; Mills PC
    Vet Immunol Immunopathol; 2011 Jan; 139(1):50-6. PubMed ID: 20846729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammary carcinoma with sebaceous differentiation in a dog.
    Chang SC; Liao JW; Wong ML; Lai YS; Liu CI
    Vet Pathol; 2007 Jul; 44(4):525-7. PubMed ID: 17606516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.